NCT03907930

Brief Summary

prospective randomized study measuring the safety and efficacy of tubeless PNL in patients at assiut university hospital comparing to the standard PNL

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

March 28, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 9, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

April 9, 2019

Status Verified

April 1, 2019

Enrollment Period

1 year

First QC Date

March 28, 2019

Last Update Submit

April 8, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • number of days of hospital stay for both groups

    comparison between number of days in hospital for both groups

    15 days

  • dose of analgesia used to control pain after the procedure

    comparison between the dose of analgesia needed for both groups in milligram

    5 days

Study Arms (2)

conventional

ACTIVE COMPARATOR

this arm will have both nephrostomy tube and ureteric catheter after completing the operation

Procedure: percutaneous nephrolithotripsy

tubeless

ACTIVE COMPARATOR

the arm will have only ureteric catheter rafter completing the operation

Procedure: percutaneous nephrolithotripsy

Interventions

removal of kidney and upper ureteric stones through small incision in the loin using nephroscope after disintegration by lithoclast

Also known as: PCNL
conventionaltubeless

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients above 18 years old 2. Patients with any stone burden and stone number requiring single procedure

You may not qualify if:

  • Patients aged below 18 years old. 2. Anatomical variation of the kidney in shape or position, e.g. horseshoe kidney or malrotation.
  • \. Complex or staghorn stones requiring staged procedure.
  • Intra operative criteria:
  • \. Three or more access tracts. 5. Significant intraoperative bleeding. 6. Intraoperative pelvi calyceal system perforation. 7. Residual stones necessitate 2nd look PNL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit University Hospitals

Asyut, Egypt

RECRUITING

Related Publications (2)

  • Fernstrom I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976;10(3):257-9. doi: 10.1080/21681805.1976.11882084.

    PMID: 1006190BACKGROUND
  • Valdivia Uria JG, Valle Gerhold J, Lopez Lopez JA, Villarroya Rodriguez S, Ambroj Navarro C, Ramirez Fabian M, Rodriguez Bazalo JM, Sanchez Elipe MA. Technique and complications of percutaneous nephroscopy: experience with 557 patients in the supine position. J Urol. 1998 Dec;160(6 Pt 1):1975-8. doi: 10.1016/s0022-5347(01)62217-1.

    PMID: 9817303BACKGROUND

Study Officials

  • atef abd aziz, professor

    assuit university hospital urology departement egypt

    STUDY CHAIR

Central Study Contacts

mohamed zowita, doctor

CONTACT

mahmoud shalaby, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
triple blinded study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: group of patients will be submitted for conventional PCNL other group will be submitted to tubeless PCNL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 28, 2019

First Posted

April 9, 2019

Study Start

March 28, 2019

Primary Completion

April 1, 2020

Study Completion

May 1, 2020

Last Updated

April 9, 2019

Record last verified: 2019-04

Locations